Pregabalin dependence: Experiences from liaison psychiatric settings in Kashmir, North India: A case series
Pregabalin, a gamma-aminobutyric acid (GABA) analog, is a new-generation antiepileptic that is approved for the treatment of neuropathic pain, fibromyalgia, partial seizures, and generalized anxiety disorder. There is a rising concern regarding its abuse potential, and a handful of case reports have highlighted the same. We present a case series on pregabalin dependence. In contrast to previous case reports, which focused on patients with a history of illicit drug abuse, we present cases of drug-naïve individuals for whom pregabalin was the first substance of abuse. The highlight of the study is that we describe cases of pregabalin intoxication and a rare case of pregabalin withdrawal, which presented as a lethal suicidal attempt to liaison psychiatric settings.
Authors
- Iqra Arshad
- Rajnish Raj (ORCID: https://orcid.org/0009-0004-8174-4390)
- Zaid Ahmad Wani (ORCID: https://orcid.org/0000-0003-4440-0092)
- Aaliya Khanam (ORCID: https://orcid.org/0000-0002-8395-3346)
- Yasir Hassan Rather
Institutions
- Government Medical College (IN)
- Institute of Mental Health and Neurosciences
Publication Details
- Journal
- Industrial Psychiatry Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/ipj.ipj_474_24
- Citations
- 1
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.81